2',3'-二脱氧腺苷; 双脱氧腺嘌呤核苷; 2,3-二脱氧腺苷; 2',3'-双脱氧腺甙; 二脱氧腺(嘌呤核)苷; DDA; 2',3'-双脱氧腺苷
DDA; ((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)methanol; [(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methanol; Dideoxyadenosine; Didanosine impurity G; 6-Amino-9-(2',3'-dideoxy-b-D-glycero-pentofuranosyl)purine; EINECS 223-853-2; [(2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl]methanol; 2-furanmethanol, 5-(6-amino-9H-purin-9-yl)tetrahydro-, (2S,5R)-; 2',3'-Dideoxyadenosine; 9-(2,3-Dideoxy-β-D-ribofuranosyl)adenine; MFCD00010534; 9-(2,3-Dideoxy-beta-D-ribofuranosyl)adenine; [(2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydro-2-furanyl]methanol; 2,3-Dideoxyadenosine; Acerola; [5-(6-amino-9H-purin-9-yl)tetrahydrofuran-2-yl]methanol; Adenosine, 2',3'-dideoxy-
本品应密封于0~4℃保存。
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:6 4.可旋转化学键数量:2 5.互变异构体数量:3 6.拓扑分子极性表面积99.1 7.重原子数量:17 8.表面电荷:0 9.复杂度:279 10.同位素原子数量:0 11.确定原子立构中心数量:2 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1